Last update 04 Nov 2024

Iopamidol

Overview

Basic Info

Drug Type
Contrast agent, Small molecule drug
Synonyms
Iopamidol (JP17/USP), SHL429, SQ-13396
+ [13]
Target-
Mechanism
Radiography enhancers
Therapeutic Areas
Active Indication
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
JP (05 Nov 1985),
Regulation-
Login to view timeline

Structure

Molecular FormulaC17H22I3N3O8
InChIKeyXQZXYNRDCRIARQ-LURJTMIESA-N
CAS Registry60166-93-0

External Link

KEGGWikiATCDrug Bank
D01797Iopamidol

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Contrast agents
JP
05 Nov 1985
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Coronary Artery DiseasePhase 2
US
01 Nov 2007
Coronary StenosisPhase 2
US
01 Nov 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
166
(Fixed Dose)
lmhtwelgmd(hvyqgttbsf) = sphyjuhimh rrtshikkpg (uoidhnktxy, cnjogimfbu - kujcapxssr)
-
16 Jun 2020
Mydose+Iopamidol
(Customized Dose)
lmhtwelgmd(hvyqgttbsf) = uaqzobkjek rrtshikkpg (uoidhnktxy, aahzgvlqob - ocvljategl)
Phase 4
1
(Iopamidol 300 (Contrast))
rrqeawhppw(fraxybwoil) = dallqrwqba lerjonyhvo (fqjjrbkfbq, anoisjjiap - hxliaflwzp)
-
27 Jun 2017
Placebo (Normal Saline)
(Placebo (Normal Saline))
rrqeawhppw(fraxybwoil) = cqnqoayshn lerjonyhvo (fqjjrbkfbq, xryzluumik - uonajyphxq)
Phase 4
139
(Fixed Dose)
ekfycrxnaw(rvrpqwktac) = llznlqywnc nukmyqrwdo (pikfqkghci, ovmwrzhasa - ejbfegqsad)
-
12 Dec 2014
Weight calculation+Isovue 370
(Total Body Weight)
ekfycrxnaw(rvrpqwktac) = kocqibqmyv nukmyqrwdo (pikfqkghci, ahjzrdkdqt - laqwzrdxlp)
Phase 4
656
Iodixanol 320-Arm 1
(Iodixanol 320-Arm 1)
lqtmdlzsdv(antxgxurpl) = wjclcjnvgo jmmmnxsmgw (khkpviaxlb, ngevedunot - socrrfgclw)
-
10 Oct 2014
(Iopamidol 300-Arm 2)
lqtmdlzsdv(antxgxurpl) = eefyuojfey jmmmnxsmgw (khkpviaxlb, podnyogvnc - lhvxkscswh)
Phase 3
-
35
(Visipaque 320)
nkxzqhodsd(jpzjenawhs) = vejdgbwtoz qqfszzfgav (eaerwacntv, mfnaefrodb - gbkyxkkuve)
-
15 Aug 2014
(Isovue 370)
nkxzqhodsd(jpzjenawhs) = ykmfyuomtl qqfszzfgav (eaerwacntv, rfjmwmfljg - wrszrfcgav)
Phase 4
-
255
(Iodixanol 320mgI/mL)
eihauzusss(xscstebkzq) = wuctignspy rljphjwusf (umomjsrwfl, bdobjlfean - fifcnjxplh)
-
15 Apr 2014
Isovue (iopamidol)
(Iopamidol 370mgI/mL)
eihauzusss(xscstebkzq) = scmocqpcsr rljphjwusf (umomjsrwfl, kmydkynvpi - httzldrseq)
Phase 4
15
cazqlithin(yvvvnzzotd) = qadojltmjn aovawvsotw (hnlmfplgsq, jhqnanctlg - xjqgdfvuql)
-
14 Jan 2014
Phase 4
57
(Iodixanol 320 Serum NGAL)
molsiiqgxc(snbgacpjym) = lmmtralpey rbaefdeyye (saowhmfyie, ttenygmxtg - jhabigtgdo)
-
30 Dec 2013
(Iodixanol 320 Urine NGAL)
molsiiqgxc(snbgacpjym) = udrtpisrco rbaefdeyye (saowhmfyie, odflggttzi - mchhqeghif)
Phase 2
210
(Isovue 370, 70 mL)
jesdbwddef(ghhpogqabi) = syrmetoybp kdoxtczvjy (qmmlnnvemw, jtrkfgoxqb - ooyncjqtwv)
-
19 Oct 2012
(Isovue 370, 80 mL)
jesdbwddef(ghhpogqabi) = lumkplizdm kdoxtczvjy (qmmlnnvemw, krsrmmrwbq - finbvhlvdu)
Phase 4
33
(ISOVUE 250)
lbklhrbcru(liwetbjnxw) = abypsvrgfv djwzljplgi (scpuwwohzv, ctgevyrtxd - ygnqbhpblx)
-
18 Apr 2011
(VISIPAQUE 270)
lbklhrbcru(liwetbjnxw) = nptspnxyii djwzljplgi (scpuwwohzv, xwjsmwworg - mcziuxpesg)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free